Clinical Biochemistry

Papers
(The H4-Index of Clinical Biochemistry is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Editorial Board87
The significance of PCSK-9′s level and polymorphism in premature coronary artery disease: Relation to risk and severity79
Reply to Letter to the Editor “The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients”70
IL-23 and IL-17 in acute ischemic stroke: Correlation with stroke scales and prognostic value32
Serum levels of sonic hedgehog in patients with IgA nephropathy are closely associated with intrarenal arteriolar lesions27
Biomarkers in the prognostic evaluation of ischemic stroke: Is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase?26
Relationship between analytical imprecision and coefficient of determination (R2) of the calibration curve24
Measuring copeptin, a surrogate for vasopressin in patients with hypertension – Can it identify those who are volume Responsive?23
A circRNA-based ceRNA network shows its diagnostic value in non-small-cell lung cancer22
Comparison of two (data mining) indirect approaches for between-subject biological variation determination22
The pitfalls and significance of using ratios and calculated parameters in laboratory medicine21
Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the harris-boyd method21
Hydroxocobalamin does not interfere with high-sensitivity cardiac troponin T assay21
Editorial Board20
Reducing AST orders by reviewing test panels20
Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves’ disease and predictors of responsiveness to methimazole20
Editorial Board20
Defining blood gas analysis stability limits across five sample types19
Limited incremental value of growth differentiation factor 15 in the initial evaluation of low and intermediate risk acute chest pain patients19
0.10908913612366